Calumet, Inc. CLMT Gain (Loss) on Sale of Assets and Asset Impairment Charges
Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Calumet, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.
The official record: Calumet, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges?
- Calumet, Inc. (CLMT) reported gain (loss) on sale of assets and asset impairment charges of -$325K in Q4 2025.
- How has Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges increased by 35.0% year-over-year, from -$500K to -$325K.
- What is the long-term trend for Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges?
- Over 3 years (2022 to 2025), Calumet, Inc.'s gain (loss) on sale of assets and asset impairment charges has grown at a 22.9% compound annual growth rate (CAGR), from -$700K to -$1.3M.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- The net impact of gains or losses from the disposal of property, plant, and equipment, combined with charges related to the impairment of asset carrying values. This provides insight into the company's asset management effectiveness and the recoverability of its capital investments.